Laboratorios Farmaceuticos Rovi, S.A.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ROVI.MC | AAREYDRUGS.NS | HYPE3.SA | LP6.F | OFSA3.SA | 7148.KL | |
|---|---|---|---|---|---|---|
| Market cap | 3.47B | 3.49B | 15.26B | 2.33B | 1.34B | 1.11B |
| P/E (TTM) | 18.7 | 74.4 | 8.1 | 11.9 | 5.7 | 10.5 |
| Forward P/E | 20.7 | — | 7.1 | — | 12.0 | 10.1 |
| Price/book | 5.0 | 2.1 | 1.0 | 1.3 | 1.6 | 1.4 |
| Dividend yield | 1.50% | — | 4.86% | 7.18% | 5.18% | 3.92% |
| 1-year change | +15.91% | +10.12% | −12.27% | −23.98% | +10.32% | −7.20% |
| Today | +6.43% | +0.08% | +2.90% | +0.77% | +1.34% | −0.86% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All ROVI.MC news ›Laboratorios Farmaceuticos Rovi, S.A. Maintains Earnings Guidance for 2026
Laboratorios Farmaceuticos Rovi, S.A. maintained earnings guidance for 2026. For the period, the company continues to expect operating revenue to increase by a low to mid-single-digit percentage... Laboratorios Farmaceuticos Rovi, S.A.…
Transcript : Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Presenter SpeechMarta Campos Martinez Hello, everyone. This is Marta Campos, Head of Finance for ROVI. Welcome to our company's review of business results for the first half of 2026. Before we Laboratorios Farmaceuticos Rovi, S.A.…
Laboratorios Farmaceuticos Rovi S A : First nine months 2026 results press release
Published on 11/05/2026 at 01:58 am EST In light of the strong performance delivered during the first nine months of 2026 and the visibility for the remainder of the year, ROVI upgrades its 2026 operating revenue guidance. The Company now…
Laboratorios Farmaceuticos Rovi, S.A.: Relative Strength Chart - Stock BME
Compare Laboratorios Farmaceuticos Rovi, S.A. with the company of your choice via a Relative Strength chart. Real-time ROVI price, BME stock exchange Relative Strength Chart Laboratorios Farmaceuticos Rovi, S.A. All financial news and data…
Laboratorios Farmaceuticos Rovi, S.A.: Total Return chart (Dividends reinvested) - BME stock market
See the history of Laboratorios Farmaceuticos Rovi, S.A., with dividends reinvested. (Total Return chart) ROVI Stock market Total Return chart Laboratorios Farmaceuticos Rovi, S.A. Past dividends on Laboratorios Farmaceuticos Rovi, S.A.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com7
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.